Catalyst Wire Dossier Catalyst Wire Dossier

Tumor necrosis factor

tumor necrosis factor
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Tumor necrosis factor, covering 2013-07-16 to 2023-10-31. Get the full timeline:

Most recent: Clinical Trial Update: Isolated Limb Perfusion of Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Soft Tissue Sarcoma of the Arm or Leg [Phase 2]

See pricing